Luís J. Nannini

National University of Rosario — Argentina

Medicine · Health Sciences

23h-index2.1kcitations73works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(52), Chronic Obstructive Pulmonary Disease (COPD) Research(32), Inhalation and Respiratory Drug Delivery(19), Respiratory and Cough-Related Research(18), Respiratory Support and Mechanisms(16)

Publications73 total

The Feasibility and Impact of Implementing Interventions to Reduce Short-Acting β2-Agonist Over-Reliance in Asthma: An Expert Opinion
Advances in Therapy·2025Open Access
Mitigating systemic corticosteroid risks in COPD: A call for earlier triple therapy initiation
Pulmonary Pharmacology & Therapeutics·2025
The Reliever Reliance Test: evaluating a new tool to address SABA over-reliance
npj Primary Care Respiratory Medicine·2024· 2 citedOpen Access
Comparing SABA-free asthma management with Primary care SABA users.
2024
Introducing the concept of loss of corticosteroid credit in asthma
Journal of Asthma·2024· 1 cited
Review for "Progress in diagnosis and treatment of difficult-to-treat asthma in children"
2023
Review for "Progress in diagnosis and treatment of difficult-to-treat asthma in children"
2023
Bronchodilator responsiveness testing with inhaled budesonide/formoterol in asthma
Journal of Asthma·2023
La única víscera sensible que tienen es el bolsillo
Revista americana de medicina respiratoria·2023Open Access
Achieving zero asthma-related hospitalisations in the world´s first SABA-free Asthma Center in Argentina
Figshare·2023Open Access
It is time to end our love affair with short-acting β<sub>2</sub>-agonists in asthma? Yes
ERJ Open Research·2022· 1 citedOpen Access
Achieving zero asthma-related hospitalisations in the world´s first SABA-free Asthma Center in Argentina
Journal of Asthma·2022· 2 cited
Review for "Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease"
2022
Bronchodilator responsiveness testing with inhaled budesonide/formoterol in asthma.
05.01 - Airway pharmacology and treatment·2022· 1 cited
SABA-free asthma management challenged by refer id asthma questionnaire.
05.01 - Airway pharmacology and treatment·2022· 1 cited
Asthma-related hospitalizations after implementing SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen
European Clinical Respiratory Journal·2022· 12 citedOpen Access
Severe asthma that was endotracheally intubated 16 times in 20 years
Journal of Clinical Images and Medical Case Reports·2021Open Access
[Inhalotherapy: Recommendations for Argentina 2021].
PubMed·2021· 1 cited
Short-Acting β <sub>2</sub> -Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6
American Journal of Respiratory and Critical Care Medicine·2020Open Access
Position statement: asthma in Latin America. IS short-acting beta-2 agonist helping or compromising asthma management?
Journal of Asthma·2020· 8 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Gustavo J. Rodrigo(10), Phillippa Poole(8), Griselda Dídoli(5), Óscar Bottasso(5), María Luisa Bay(5), Toby J Lasserson(4), Néstor A. Molfino(4), Arthur S. Slutsky(4), Christopher J Cates(4), Bettina Bongiovanni(4), Luciano D’Attilio(4), Walter Gardeñez(4), Hugo Neffen(3), Natalia Santucci(3), Hugo O. Besedovsky(3), Adriana del Rey(3), Nadia Brandan(3), O Fernández(3), Daniela Marchiori Flores(3), Stephen J Milan(2)